Home » Topics » Disease categories and therapies » Immune

Immune
RSS

First demonstration of prolonged graft survival with a rationally designed IMPDH inhibitor

July 2, 1999

Jak3 tyrosine kinase inhibitor prolongs allograft survival in rat model

July 2, 1999

IL-15 can act as a substitute for IL-2 in the rejection process

July 2, 1999

Results of European studies on sirolimus discussed at Oslo congress

July 1, 1999

Novartis improves upon an effective transplant drug

July 1, 1999

Acellular pertussis vaccine approved in Canada for adults, adolescents

July 1, 1999

SmithKline Beecham launches new combined vaccine for hepatitis A and typhoid in the U.K.

June 30, 1999

New hepatitis A vaccine affords protection with first dose

June 30, 1999

Sumitomo presents new inhibitors of STAT6 activation

June 29, 1999

Chimeric Therapies initiates pivotal trial evaluating proprietary method for allogeneic BMT

June 25, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...